Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Acne
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Acne
    Low-Dose, Drospirenone-Containing Oral Contraceptive Approved in Europe - (DGNews)
    Combination Topical Therapy Effective And Safe for Moderate and Moderate-Severe Acne: Presented at AAD - (DGDispatch)
    Treatment of Mild to Moderate Acne: Presented at AAFP - (DGDispatch)
    Contraceptive Pill Effective Against Adult Acne When Compared With Placebo: Presented at ACOG - (DGDispatch)
    Teens' Stress Levels Linked to Acne Severity - (DGNews)

    News archive

     Recent webcasts/CME - Acne
      What Lies Beneath: Taking a Deeper Look at Acne Patient Care Strategies
      Advances in Dermatological Care: What the Family Physician Needs to Know

      Webcasts/CME archive

       Recent cases - Acne
        Interstitial Pneumonia and Hepatitis Caused by Minocycline
        Minocycline-Induced Hyperpigmentation of the Tongue

        Cases archive
          




        my personal edition > acne > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Single Pulsed-Dyed Laser Treatment Improved Inflammatory Acne

        Lancet

        10/27/2003
        By Joene Hendry


        Pulsed-dye laser therapy resulted in substantial improvement in acne severity in a small group of patients with inflammatory acne vulgaris, researchers report.

        Between November 2001 and April 2001, E. D. Seaton, MRCP, Imperial College, London, United Kingdom, and colleagues randomised 41 patients, (aged from 20 to 36 years, acne duration 5 to 26 years), to either a single pulsed-dye laser (PDL) treatment (n=31) or a sham treatment (n=10). Laser treatments were delivered at 2 fluences, 1.5 J/cm squared and 3.0 J/cm squared, on opposite sides of the midline to allow subgroup analysis of the effect of dosage.

        The investigators assessed acne severity at baseline and 12 weeks after treatment using the Leeds revised grading system. They also assessed adverse events and any changes in lesion counts in the study group. Patients did not use acne treatments during the study period and were free of oral antibiotics for 4 weeks, cyproterone acetate-containing contraceptives for 12 weeks, oral isotretinoin for 52 weeks, and topical treatment for 2 weeks prior to study entry.

        Acne severity reduced from 3.8 at baseline to 1.9 after 12 weeks in the PDL group compared with 3.6 to 3.5 in the control group. Total lesion counts fell by 53% compared with 9% in the PDL and control groups, respectively while inflammatory lesion counts fell by 49% in the PDL group compared with 10% in controls. The investigators found no significant differences in the change in lesion counts at different fluences in the laser group.

        Four patients in the PDL group withdrew (3 patients moved, 1 required systemic antibiotic treatment for worsening truncal acne) while 1 control patient withdrew due to dissatisfaction with clinical response. Adverse events included pain, transient purpura, pruritus, dry skin or lips, and watery eye in 6 of the PDL treated patients compared with 2 control patients who reported pruritus and dry skin. The 2 laser patients who reported moderate transient discomfort during irradiation at a high fluence both had deeply pigmented Afro-Caribbean skin.

        "Our results suggest that this laser treatment could be developed as a new therapeutic approach that would allow simultaneous treatment of both active acne and associated scarring," the authors conclude, adding that "laser treatment should be further explored as an adjuvant or alternative to daily conventional pharmacological treatments."

        Lancet 2003;362:1347-52.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send